Acute Inflammatory Response Following Increased Blood-Brain Barrier Permeability Induced by Focused Ultrasound is Dependent on Microbubble Dose

Rationale: Focused ultrasound (FUS), in conjunction with circulating microbubbles (MBs), can be used to transiently increase the permeability of the blood-brain barrier (BBB) in a targeted manner, allowing therapeutic agents to enter the brain from systemic circulation. While promising preclinical work has paved the way for the initiation of 3 human trials, there remains concern regarding neuroinflammation following treatment. The aim of this study was to assess the magnitude of this response following sonication and explore the influence of MB dose. Methods: Differential expression of NFκB signaling pathway genes was assessed in rats at 6 h and 4 days following a FUS-mediated increase in BBB permeability. Three sonication schemes were tested: (1) a clinical imaging dose of MBs + peak negative pressure (PNP) controlled by acoustic feedback, (2) 10x clinical imaging dose of MBs + constant PNP of 0.290 MPa, and (3) 10x clinical imaging dose of MBs + PNP controlled by acoustic feedback. Follow-up magnetic resonance imaging (MRI) was performed to assess edema and hemorrhage. Hematoxylin and eosin histology was used to evaluate general tissue health. Results: MB dose has a significant impact on the expression of several key genes involved in acute inflammation and immune activation, including Tnf, Birc3, and Ccl2. At a clinical imaging dose of MBs, there were no significant changes detected in the expression of any NFκB signaling pathway genes. Conversely, a high MB dose resulted in a clear activation of the NFκB signaling pathway, accompanied by edema, neuronal degeneration, neutrophil infiltration, and microhemorrhage. Results also suggest that post-FUS gadolinium enhancement may hold predictive value in assessing the magnitude of inflammatory response. Conclusion: While a significant and damaging inflammatory response was observed at high MB doses, it was demonstrated that FUS can be used to induce increased BBB permeability without an associated upregulation of NFκB signaling pathway gene expression. This emphasizes the importance of employing optimized FUS parameters to mitigate the chances of causing injury to the brain at the targeted locations.

[1]  T. Yen,et al.  SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery. , 2013, Biomaterials.

[2]  K. Hynynen,et al.  Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[3]  K. Hynynen,et al.  Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. , 2001, Radiology.

[4]  Chih-Kuang Yeh,et al.  Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. , 2012, Biomaterials.

[5]  Mary P. Stenzel-Poore,et al.  Mechanisms of ischemic brain damage , 2008, Neuropharmacology.

[6]  K. Hynynen,et al.  Gene delivery to the spinal cord using MRI-guided focused ultrasound , 2015, Gene Therapy.

[7]  M. Yenari,et al.  Post-ischemic inflammation: molecular mechanisms and therapeutic implications , 2004, Neurological research.

[8]  M. Morganti-Kossmann,et al.  Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. , 1998, Journal of neurotrauma.

[9]  Natalia Vykhodtseva,et al.  Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. , 2012, Ultrasound in medicine & biology.

[10]  Neekita Jikaria,et al.  Disrupting the blood–brain barrier by focused ultrasound induces sterile inflammation , 2016, Proceedings of the National Academy of Sciences.

[11]  Rajiv Chopra,et al.  Antibodies Targeted to the Brain with Image-Guided Focused Ultrasound Reduces Amyloid-β Plaque Load in the TgCRND8 Mouse Model of Alzheimer's Disease , 2010, PloS one.

[12]  Luis Solorio,et al.  Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents. , 2013, Ultrasound in medicine & biology.

[13]  W. Pardridge.  The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[14]  K. Hynynen,et al.  Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome , 2017, Scientific Reports.

[15]  T. Yen,et al.  Focused Ultrasound-Induced Blood–Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study , 2013, PloS one.

[16]  Neil Humphreys,et al.  Chronic Systemic Infection Exacerbates Ischemic Brain Damage via a CCL5 (Regulated on Activation, Normal T-Cell Expressed and Secreted)-Mediated Proinflammatory Response in Mice , 2010, The Journal of Neuroscience.

[17]  F. Tortella,et al.  Quantitative Real-Time RT—PCR Analysis of Inflammatory Gene Expression Associated with Ischemia—Reperfusion Brain Injury , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  P. Dash,et al.  Altered expression of miRNA‐21 and its targets in the hippocampus after traumatic brain injury , 2011, Journal of neuroscience research.

[19]  Kullervo Hynynen,et al.  Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. , 2012, Radiology.

[20]  A. Helmy,et al.  Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury , 2011, Progress in Neurobiology.

[21]  K. Hynynen,et al.  Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study. , 2007, Ultrasound in Medicine and Biology.

[22]  Natalia Vykhodtseva,et al.  MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. , 2005, Ultrasound in medicine & biology.

[23]  K. Hynynen,et al.  Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[24]  Natalia Vykhodtseva,et al.  Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI‐guided focused ultrasound , 2007, International journal of cancer.

[25]  F. Tortella,et al.  Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: Relation to nuclear factor κB (NF-κB), inflammatory gene expression, and leukocyte infiltration , 2006, Neurochemistry International.

[26]  G. Lazzarino,et al.  Biochemical and neurochemical sequelae following mild traumatic brain injury: summary of experimental data and clinical implications. , 2010, Neurosurgical focus.

[27]  Kullervo Hynynen,et al.  Targeted Delivery of Neural Stem Cells to the Brain Using MRI-Guided Focused Ultrasound to Disrupt the Blood-Brain Barrier , 2011, PloS one.

[28]  K. Hynynen,et al.  Focused ultrasound delivers targeted immune cells to metastatic brain tumors. , 2013, Cancer research.

[29]  Vincent P. Ferrera,et al.  Long-Term Safety of Repeated Blood-Brain Barrier Opening via Focused Ultrasound with Microbubbles in Non-Human Primates Performing a Cognitive Task , 2015, PloS one.

[30]  Ferenc A. Jolesz,et al.  Local and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications , 2005, NeuroImage.

[31]  Yao-Sheng Tung,et al.  Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. , 2010, Ultrasound in medicine & biology.

[32]  Mickael Tanter,et al.  Dynamic Study of Blood–Brain Barrier Closure after its Disruption using Ultrasound: A Quantitative Analysis , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  Chunyi Zhang,et al.  Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus. , 2002, Brain research.

[34]  Matthew E. Downs,et al.  Correction: Long-Term Safety of Repeated Blood-Brain Barrier Opening via Focused Ultrasound with Microbubbles in Non-Human Primates Performing a Cognitive Task , 2015, PloS one.

[35]  Natalia Vykhodtseva,et al.  Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. , 2012, Cancer research.

[36]  K. Hynynen,et al.  Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. , 2006, Biochemical and biophysical research communications.

[37]  G. Huberfeld,et al.  Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model. , 2017, Journal of neurosurgery.